Chasing Pfizer, Antares advances rescue med into pivotal trialnews2022-01-18T13:33:01+00:00January 18th, 2022|Fierce Pharma|
Ori Biotech reaps $100M in series B round to help launch innovative cell manufacturing technews2022-01-18T13:28:42+00:00January 18th, 2022|Fierce Pharma|
Fierce JPM Week: 5 industry execs discuss pandemic supply chain issues, solutionsnews2022-01-18T11:46:01+00:00January 18th, 2022|Fierce Pharma|
GlaxoSmithKline rejects Unilever’s $68B consumer health buyout offer, but a bigger bid is brewingnews2022-01-18T11:27:08+00:00January 18th, 2022|Fierce Pharma|
GSK, Vir file for emergency FDA authorization of intramuscular formulation of COVID-19 antibodynews2022-01-18T11:04:52+00:00January 18th, 2022|Fierce Pharma|
Journey of Vyne’s topical drugs continues with $20M dealnews2022-01-18T11:01:21+00:00January 18th, 2022|Fierce Pharma|
Stanford spinout forms drug delivery joint venture with Chinese biotechnews2022-01-18T10:57:39+00:00January 18th, 2022|Fierce Pharma|
Daiichi Sankyo, with tighter focus on oncology, sells 8 aging US cardiovascular drugs to diversifying Cosettenews2022-01-18T02:43:28+00:00January 18th, 2022|Fierce Pharma|
Tapping new tech helps marketers matchmake rare disease drugs for elusive patientsnews2022-01-14T22:31:07+00:00January 14th, 2022|Fierce Pharma|
Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust casenews2022-01-14T21:34:05+00:00January 14th, 2022|Fierce Pharma|
